Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Caspofungin and Polymyxin B Reduce the Cell Viability and Total Biomass of Mixed Biofilms of Carbapenem-Resistant Pseudomonas aeruginosa and Candida spp.

Texto completo
Autor(es):
Fernandes, Luciana [1] ; Fortes, Bruna Nakanishi [1] ; Lincopan, Nilton [1] ; Ishida, Kelly [1]
Número total de Autores: 4
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo Científico
Fonte: FRONTIERS IN MICROBIOLOGY; v. 11, DEC 16 2020.
Citações Web of Science: 1
Resumo

Pseudomonas aeruginosa and Candida spp. are biofilm-forming pathogens commonly found colonizing medical devices, being mainly associated with pneumonia and bloodstream infections. The coinfection by these pathogens presents higher mortality rates when compared to those caused by a single microbial species. This study aimed to evaluate the antibiofilm activity of echinocandins and polymyxin B (PMB) against polymicrobial biofilms of carbapenem-resistant (CR) Pseudomonas aeruginosa and Candida spp. (C. albicans, C. parapsilosis, C. tropicalis, and C. glabrata). In addition, we tested the antimicrobial effect on their planktonic and monomicrobial biofilm counterparties. Interestingly, beyond inhibition of planktonic {[}minimum inhibitory concentration (MIC) = 0.5 mu g/ml] and biofilm {[}minimum biofilm inhibitory concentration (MBIC)(50) <= 2-8 mu g/ml] growth of P. aeruginosa, PMB was also effective against planktonic cells of C. tropicalis (MIC = 2 mu g/ml), and polymicrobial biofilms of CR P. aeruginosa with C. tropicalis (MBIC50 <= 2 mu g/ml), C. parapsilosis (MBIC50 = 4-16 mu g/ml), C. glabrata (MBIC50 = 8-16 mu g/ml), or C. albicans (MBIC50 = 8-64 mu g/ml). On the other hand, while micafungin (MFG) showed highest inhibitory activity against planktonic (MIC <= 0.008-0.5 mu g/ml) and biofilm (MBIC50 <= 2-16 mu g/ml) growth of Candida spp.; caspofungin (CAS) displays inhibitory activity against planktonic cells (MIC = 0.03-0.25 mu g/ml) and monomicrobial biofilms (MBIC50 <= 2-64 mu g/ml) of Candida spp., and notably on planktonic and monomicrobial biofilms of CR P. aeruginosa (MIC or MBIC50 >= 64 mu g/ml). Particularly, for mixed biofilms, while CAS reduced significantly viable cell counts of CR P. aeruginosa and Candida spp. at >= 32 and >= 2 mu g/ml, respectively; PMB was effective in reducing viable cells of CR P. aeruginosa at >= 2 mu g/ml and Candida spp. at >= 8 mu g/ml. Similar reduction of viable cells was observed for CAS (32-64 mu g/ml) combined with PMB (2 mu g/ml). These findings highlight the potential of PMB and CAS for the treatment of polymicrobial infections caused by Candida spp. and critical priority CR P. aeruginosa. (AU)

Processo FAPESP: 17/26076-4 - Efeito dos antimicrobianos na infecção polimicrobiana de Aspergillus fumigatus e Pseudomonas aeruginosa
Beneficiário:Bruna Nakanishi Fortes
Modalidade de apoio: Bolsas no Brasil - Iniciação Científica
Processo FAPESP: 17/19374-9 - Equinocandinas no controle de infecções associadas a biofilmes polimicrobianos de Candida spp. e bactérias como Stapholococcus aureus e Pseudomonas aeruginosa
Beneficiário:Kelly Ishida
Modalidade de apoio: Auxílio à Pesquisa - Regular